Octagon Capital Advisors LP Merus N.V. Call Options Transaction History
Octagon Capital Advisors LP
- $301 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MRUS
# of Institutions
198Shares Held
62.3MCall Options Held
355KPut Options Held
96.5K-
Wellington Management Group LLP Boston, MA4.72MShares$189 Million0.04% of portfolio
-
Commodore Capital LP New York, NY4.47MShares$179 Million18.43% of portfolio
-
Rtw Investments, LP New York, NY4.17MShares$167 Million2.88% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.37MShares$135 Million7.27% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.17MShares$127 Million3.38% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $1.84B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...